Localization of IL-1, IL-2, IL-4, IL-8 and TNF in superficial bladder tumors treated with intravesical bacillus Calmette-Guerin

Journal of Urology

Volumn 156, Issue 2, 1996, Pages 536-541

  Sander, Birgitta ^a   Damm, Ole ^b   Gustafsson, Bertil ^b   Andersson, Ulf ^b   Håkansson, Leif ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b NONE

Author keywords

BCG vaccine; Bladder neoplasms; Cytokines; Immunohistochemistry

Indexed keywords

BCG VACCINE; COLORING AGENT; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; CELL CULTURE; CHEMISTRY; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; METABOLISM; TRANSITIONAL CELL CARCINOMA;

ADMINISTRATION, INTRAVESICAL; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; COLORING AGENTS; HUMANS; INTERLEUKINS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; URINARY BLADDER NEOPLASMS;

EID: 0030211314     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65921-4     Document Type: Article

References (20)

1. Morales, A., Eidinger, D. and Bruce, A. W.: Intracavity bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J. Urol., 116: 180, 1976.
2. Ratliff, T. L.: Role of the immune response in BCG for bladder cancer. Eur. Urol., suppl. 2, 21: 17, 1992.
3. Haaff, E. O., Catalona, W. J. and Ratliff, T. L.: Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG. J. Urol., 136: 970, 1986.
4. Fleishmann, J. D., Toossi, Z., Ellner, J. J., Wentworth, D. B., Ratliff, T. L. and Imbembo, A. L.: Urinary interleukins in patients receiving intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer. Cancer, 64: 1447, 1989.
5. Böhle, A., Nowc, C. H., Ulmer, A. J., Musehold, J., Gerdes, J., Hofsetter, A. G. and Flad, H.-D.: Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy. J. Urol., 144: 59, 1990.
6. Bettex-Galland, M., Studer, U. E., Walz, A., Dewald, B. and Bagglioni, M.: Neutrophil-activating peptide-1/interleukin-8 detection in human urine during acute bladder inflammation caused by transurethral resection of superficial cancer and bacillus Calmette-Guerin administration. Eur. Urol., 19: 171, 1991.
7. De Boer, E. C., De Jong, W. H., Steerenberg, P. A., Aarden, L. A., Tetteroo, E., De Groot, E. R., Van der Meijden, A. P. M., Vegt, P. D. J., Debruyne, F. M. J. and Ruitenberg, E. J.: Induction of urinary interleukin 1 (IL-1), IL2, IL-6 and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guerin in superficial bladder cancer. Cancer Immunol. Immunother., 34: 306, 1992.
8. Sander, B., Andersson, J. and Andersson, U.: Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev., 119: 65, 1991.
9. Andersson, J., Björk, L., Dinarello, C., Towbin, H. and Andersson, U.: Monoclonal antibody two-site ELISA for human IFN-γ. Eur. J. Immunol., 22: 2617, 1992.
10. Abrams, J., Roncarolo, M., Yssel, H., Andersson, U., Gleich, G. and Silver, J.: Strategies of anti-cytokine mAb development. Immunoassays of IL-10 and IL-5 in clinical studies. Immunol. Rev., 127: 5, 1992.
11. Martich, G. D., Danner, R. L., Ceska, M. and Suffredini, A. F.: Detection of IL-8 and TNF in normal humans after intravenous endotoxin. J. Exp. Med., 173: 1021, 1991.
12. Lamche, H. R. and Adolf, G. R.: Highly sensitive enzyme immunoassay for antibodies to human TNF-α and TNF-β. J. Immunol. Methods, 131: 283, 1990.
13. Andersson, G., Ekre, H.-P., Alm, G. and Perlmann, P.: Monoclonal antibody two-site ELISA for human IFN-γ. J. Immunol. Methods, 25: 89, 1989.
14. Böhle, A., Gerdes, J., Ulmer, A. J., Hofsetter, A. G. and Flad, H.-D.: Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. J. Urol., 144: 53, 1990.
15. Boccafoschi, C., Montefiore, F., Pavesi, M., Pastormerlo, M. and Betta, P.-G.: Late effects of intravesical bacillus Calmette-Guerin immunotherapy on bladder mucosa infiltrating lymphocytes: an immunohistochemical study. Eur. Urol., 27: 334, 1995.
16. Sander, B., Skansén-Saphir, U., Damm, O., Håkansson, L., Andersson, J. and Andersson, U.: Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guerin. Immunology, 86: 512, 1995.
17. +) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J. Immunol., 148: 2058, 1992.
18. Baggiolini, M., Walz, A. and Kunkel, S. L.: Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest., 84: 1045, 1989.
19. Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russel, D. G. and Orme, I. M.: Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med., 178: 2243, 1993.
20. Barnes, P. F., Fong, S.-J., Brennan, P. J., Twomey, P. E., Mazumder, A. and Modlin, R. L.: Local production of tumor necrosis factor and IFN-γ in tuberculous pleuritis. J. Immunol., 145: 149, 1990.